SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma

Autor: Prathipati, Philip, Pathania, Anup S., Chaturvedi, Nagendra K., Gupta, Subash C., Byrareddy, Siddappa N., Coulter, Don W., Challagundla, Kishore B.
Zdroj: In Molecular Therapy - Nucleic Acids 11 June 2024 35(2)
Databáze: ScienceDirect